Tango Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-BCTG Holdings, LLC(6.5%),Aaron I. Davis(6.4%)等
Tango Therapeutics | 4:持股变动声明- Boxer Capital Management, LLC
Tango Therapeutics | 144:拟议出售证券
Tango Therapeutics | 4:持股变动声明- Boxer Capital Management, LLC
Tango Therapeutics | 144:拟议出售证券
Tango Therapeutics | 3:首次持股声明- Boxer Capital Management, LLC
Tango Therapeutics | 144:拟议出售证券
Tango Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Aaron I. Davis(7.8%),Boxer Capital Management, LLC(7.6%)等
Tango Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Braslyn Ltd.(Less than 0.1%),Joe Lewis(Less than 0.1%)等
Tango Therapeutics | 4:持股变动声明-股东 Third Rock Ventures IV, L.P.
Tango Therapeutics | 144:拟议出售证券
Tango Therapeutics | 4:持股变动声明-股东 Third Rock Ventures IV, L.P.
Tango Therapeutics | 4:持股变动声明- Davis Aaron I.
Tango Therapeutics | 144:拟议出售证券
Tango Therapeutics | 4:持股变动声明-股东 Third Rock Ventures IV, L.P.
Tango Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Third Rock Ventures IV, L.P.(15.9%),Third Rock Ventures GP IV, L.P.(15.9%)等
Tango Therapeutics | 144:拟议出售证券
Tango Therapeutics | 4:持股变动声明-股东 Third Rock Ventures IV, L.P.
Tango Therapeutics | 144:拟议出售证券
Tango Therapeutics | 4:持股变动声明-股东 Third Rock Ventures IV, L.P.
暂无数据
暂无数据